CTRI/2018/11/016345进行中（未招募）3 期
A prospective study to evaluate the feasibility of hippocampal sparing intensity modulated radiotherapy in preserving neurocognitive functions in adult patients with pituitary adenoma.
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Patients must provide study-specific informed consent prior to study enrolment
- •2.Indication for adjuvant /radical radiotherapy
- •3.Patients who are treated in TMH Mumbai / ACTREC Navi Mumbai
- •4.Age > 18years
- •5.Patients consenting for the study
- •6.Karnofsky Performance Score of > 70
排除标准
- •1. Prior history of irradiation to head & neck region
- •2. Contraindication to MR imaging such as implanted metal devices, severe claustrophobia etc
- •3. Acute medical illness requiring intensive medical care.
- •4. Any evidence of chronic / severe or uncontrolled medical illnesses
- •5. Patients with known major psychiatric illness, on antipsychotic medications and/or on electroconvulsive therapy.
研究者
相似试验
招募中
1 期
A prospective study to evaluate the feasibility and usefulness of a smartphone site aimed at improving taste disorders and nutritional status in cancer patients undergoing chemotherapyJPRN-UMIN000046647ational Cancer Center Hospital,230
招募中
不适用
A prospective study evaluating the feasibility and safety of EUS-guided biliary drainage using a modified repositionable plastic stentCases requiring biliary drainage due to biliary disease (including benign and malignant disease)JPRN-UMIN000048423Tokyo Medical University100
尚未招募
不适用
Assessing the feasibility of microdialysis to monitor vascular endothelial function in paediatric cardiac patients.ACTRN12618000144213The University of Queensland40
已完成
不适用
A study to investigate the feasibility of smartphone-based self-monitoring to characterise cognitive and neurological impairment in participants with multiple sclerosis (Floodlight MS_More Active)Multiple sclerosisNervous System DiseasesISRCTN62225263F. Hoffmann-La Roche Ltd279
招募中
2 期
Stereotactic body radiation therapy in lymph nodal oligometastatic diseaseCTRI/2023/02/049773PGIMER CHANDIGARH